News
News
- Aehr Test Systems to Announce Fiscal 2020 Fourth Quarter and Full Year Financial Results on July 16, 2020
07/08/2020 / 22:05 - GlobeNewswire - CoPeace Launches Regulation CF Equity Crowdfunding Offering to Fund Impact Investing Initiatives
07/08/2020 / 15:00 - GlobeNewswire - Systematic Sampling at Novo’s Egina Mining Lease Yields Positive ‘MAK’ Gold Results
07/08/2020 / 14:13 - GlobeNewswire - Kleo Pharmaceuticals Announces $5 Million Grant to Advance Development of COVID-19 Hyperimmune Globulin Mimic (HGM) as a Therapeutic for Infected Patients
07/08/2020 / 13:30 - GlobeNewswire - Kiadis licenses previously undisclosed pre-clinical K-NK-cell programs to Sanofi, with total potential deal value of €875 million, plus royalties
07/08/2020 / 07:00 - GlobeNewswire - Kiadis to present at the Solebury Trout & Venrock EU Virtual Summer Event
07/02/2020 / 07:30 - GlobeNewswire - Rubius Therapeutics Provides Update on Clinical Trial Progress for its Lead Oncology Product Candidate RTX-240 and Announces Planned Leadership Transition
06/30/2020 / 14:00 - GlobeNewswire - Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001
06/29/2020 / 15:30 - GlobeNewswire - Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate
06/25/2020 / 15:00 - GlobeNewswire - Kiadis announces first patient enrolled in clinical study conducted at The Ohio State University in R/R AML with off-the-shelf K-NK cells from universal donors as part of its K-NK003 program
06/25/2020 / 07:00 - GlobeNewswire
Real-time